For example, the insulin-like growth factor 1 (IGF-1) pathway actives protein synthesis and inhibits degradation, thereby controlling the balance of muscle protein turnover; thus, a decline in hormones including IGF-1 and dehydroepiandrosteronesulphate (DHEAS), may contribute to development of sarcopenia [15–18]. This evidence concerns the gene IGF1 and sarcopenia.